Skjalg Bruheim
Department of Tumour Biology
Institute for Cancer Research University in Oslo
Norway
Name/email consistency: high
- Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts. Bruheim, S., Kristian, A., Uenaka, T., Suo, Z., Tsuruoka, A., Nesland, J.M., Fodstad, O. Int. J. Cancer (2011)
- Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Bruheim, S., Xi, Y., Ju, J., Fodstad, O. Clin. Cancer Res. (2009)